Article
Five-year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients after Neoadjuvant Regimens plus Surgery: a Propensity Score Matching, Real-World Cohort Study
2026-01-29
Abstract excerpt
<title>Abstract</title> <p>Background Non-pathological complete response (non-pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long-term outcome and postoperative risk stratification in the immunotherapy era remains limited. Methods We retrospectively enrolled consecutive ESCC patients treated with neoadjuvant immunochemotherapy (nICT) or chemo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eeee3e4d-2ae6-5030-91ab-ecdc4cbce268
- DOI
- 10.21203/rs.3.rs-8484860/v1
